AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories (RDY) and Sandoz
AMRI (NASDAQ: AMRI) announced that it has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories (NYSE: RDY) and Sandoz, Inc. for infringement of AMRI's U.S. Patent Number 7,390,906. The recently issued patent relates to the manufacturing process for the active ingredient in sanofi-aventis's Allegra(R) and Allegra(R)D drug products.
This legal action relates to generic versions of sanofi-aventis's Allegra(R) and Allegra(R)D drug products for which the defendants are seeking or have obtained marketing approval from the FDA and which the defendants have marketed in the United States.
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
